Björkqvist J - Search Results

1

C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk.

Schürmann D, Herzog E, Raquet E, Nolte MW, May F, Müller-Cohrs J, Björkqvist J, Dickneite G, Pragst I. Schürmann D, et al. Among authors: bjorkqvist j. Thromb Haemost. 2014 Nov;112(5):960-71. doi: 10.1160/TH13-06-0469. Epub 2014 Aug 7. Thromb Haemost. 2014. PMID: 25103795 Free PMC article.

2

A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk.

Larsson M, Rayzman V, Nolte MW, Nickel KF, Björkqvist J, Jämsä A, Hardy MP, Fries M, Schmidbauer S, Hedenqvist P, Broomé M, Pragst I, Dickneite G, Wilson MJ, Nash AD, Panousis C, Renné T. Larsson M, et al. Among authors: bjorkqvist j. Sci Transl Med. 2014 Feb 5;6(222):222ra17. doi: 10.1126/scitranslmed.3006804. Sci Transl Med. 2014. PMID: 24500405

3

Plasma kallikrein: the bradykinin-producing enzyme.

Björkqvist J, Jämsä A, Renné T. Björkqvist J, et al. Thromb Haemost. 2013 Sep;110(3):399-407. doi: 10.1160/TH13-03-0258. Epub 2013 Jul 11. Thromb Haemost. 2013. PMID: 23846131 Review.

4

In vivo activation and functions of the protease factor XII.

Björkqvist J, Nickel KF, Stavrou E, Renné T. Björkqvist J, et al. Thromb Haemost. 2014 Nov;112(5):868-75. doi: 10.1160/TH14-04-0311. Epub 2014 Sep 4. Thromb Haemost. 2014. PMID: 25187064 Review.

5

Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.

Björkqvist J, de Maat S, Lewandrowski U, Di Gennaro A, Oschatz C, Schönig K, Nöthen MM, Drouet C, Braley H, Nolte MW, Sickmann A, Panousis C, Maas C, Renné T. Björkqvist J, et al. J Clin Invest. 2015 Aug 3;125(8):3132-46. doi: 10.1172/JCI77139. Epub 2015 Jul 20. J Clin Invest. 2015. PMID: 26193639 Free PMC article.

6

Addition of prothrombin to plasma can result in a paradoxical increase in activated partial thromboplastin time.

Hansson KM, Björkqvist J, Deinum J. Hansson KM, et al. Among authors: bjorkqvist j. Blood Coagul Fibrinolysis. 2014 Dec;25(8):851-5. doi: 10.1097/MBC.0000000000000161. Blood Coagul Fibrinolysis. 2014. PMID: 25004021

7

Hereditary angioedema: a bradykinin-mediated swelling disorder.

Björkqvist J, Sala-Cunill A, Renné T. Björkqvist J, et al. Thromb Haemost. 2013 Mar;109(3):368-74. doi: 10.1160/TH12-08-0549. Epub 2013 Jan 10. Thromb Haemost. 2013. PMID: 23306453 Review.

8

Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo.

Oschatz C, Maas C, Lecher B, Jansen T, Björkqvist J, Tradler T, Sedlmeier R, Burfeind P, Cichon S, Hammerschmidt S, Müller-Esterl W, Wuillemin WA, Nilsson G, Renné T. Oschatz C, et al. Among authors: bjorkqvist j. Immunity. 2011 Feb 25;34(2):258-68. doi: 10.1016/j.immuni.2011.02.008. Immunity. 2011. PMID: 21349432 Free article.

9

Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents.

Björkqvist J, Lecher B, Maas C, Renné T. Björkqvist J, et al. Biol Chem. 2013 Sep;394(9):1195-204. doi: 10.1515/hsz-2013-0144. Biol Chem. 2013. PMID: 23640941

10

Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions.

Sala-Cunill A, Björkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, Nickel KF, Butler L, Luengo O, Kumar P, Labberton L, Long A, Di Gennaro A, Kenne E, Jämsä A, Krieger T, Schlüter H, Fuchs T, Flohr S, Hassiepen U, Cumin F, McCrae K, Maas C, Stavrou E, Renné T. Sala-Cunill A, et al. Among authors: bjorkqvist j. J Allergy Clin Immunol. 2015 Apr;135(4):1031-1043.e6. doi: 10.1016/j.jaci.2014.07.057. Epub 2014 Sep 18. J Allergy Clin Immunol. 2015. PMID: 25240785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters